MenaQ7® Vitamin K2: At the Heart of the Matter

Share this article:


Cardiovascular health remains a global concern, and one of the reasons that consumers seek protective benefits of dietary supplementation. As much as 80% of consumers in Europe and the US recognize the link between good heart health and good overall health (FMCG).

In recent years, there has been a strong focus on the role of arterial stiffness impacting cardiovascular health, as well as the discovery of the vitamin K-dependent protein Matrix Gla Protein (MGP).

MGP is the most potent modulator of vascular calcification known, provided the body has enough Vitamin K2 to activate it.

MenaQ7® is the only clinically proven Vitamin K2 as MK7 for cardiovascular health with groundbreaking studies. The 3-year study showed a nutritional dose of MenaQ7® taken daily not only inhibited age-related arterial stiffening, but also promoted vascular elasticity.

Choose MenaQ7® to support your heart health claims with science!

101 rue de Menin
59700 Marcq-en-Baroeul

Subscribe to our newsletter

The latest news, articles, and resources, sent to your inbox twice a month.

The information provided here is, to the best of our knowledge, true and accurate. However, our products must only be used in compliance with local laws and regulations. We cannot guarantee the freedom of use for every intended application or country. These statements may not have been evaluated by your local Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease. A healthy, balanced and diversified diet should fulfill all nutritional needs.